Pierce Chow

Pierce Chow is the current Chairman of the Scientific Advisory Board at AUM Biosciences. Prior to this, they were the Duke-NUS Graduate Medical School, Singapore General Hospital, NMRC Translational-Clinical Research Flagship Program in Liver Cancer, Comprehensive Liver Cancer Clinic, National Cancer Center Singapore, and National Medical Research Council, Singapore. From January 2002 to December 2005, they were the Clinical Research Director at PsiOncology where they conceptualized and led the translational and clinical research on a novel brachytherapy device for liver and pancreatic tumour, including the first-in-man study of BrachySil. Pierce has also served as the Protocol Chair for the Asia-Pacific Hepatocellular Carcinoma Trials Group.

Pierce Chow completed their MBBS at the National University of Singapore, followed by an MMed and PhD in Medicine and Surgery. Pierce then completed a FRCS in Surgery at the Royal College of Surgeons of Edinburgh.